Analysing the rules of proof in China’s first drug patent linkage suit Wu Xiaohui of Wanhuida Intellectual Property explains a pioneering case heard by the Intellectual Property Court of the Supreme People’s Court and considers its implications for original and generic drug makers... View Full Article Related Articles News Feed Don’t miss it! Join us for World Intellectual Property Day Blog by Kathi Vidal, Under Secretary of Commerce for Intellectual Property and Director of the USPTOEvery year on April 26,… Learn More News Feed Beware the Law of Unintended Consequences: The Push for Statutory Remuneration for Korean Writers and Directors Working on Streaming Projects could do more Harm than Good Copyright is very simple as a concept yet can be quite complex when it comes to actual implementation. This is… Learn More News Feed Podcasting’s Copyright Growing Pains Earlier this week, the New York Times ran a review of a new podcast by Keegan-Michael Key, of the… Learn More
